Additional Metadata
Keywords Cannabinoid 1 receptor, Metabolic risk factors, Obesity, Rimonabant
Persistent URL dx.doi.org/10.1038/ncpendmet0218
Journal Nature Clinical Practice Endocrinology and Metabolism
Citation
Abizaid, A, & Horvath, T.L. (Tamas L.). (2006). Rimonabant - A new hope in the treatment of obesity? Commentary. Nature Clinical Practice Endocrinology and Metabolism (Vol. 2, pp. 370–371). doi:10.1038/ncpendmet0218